SILVER SPRING
Ryaltris pediatric expansion cleared for ages 6-12
- Sponsor
- Glenmark Specialty S.A.
- Drug
- Ryaltris · olopatadine hydrochloride / mometasone furoate
- Indication
- Allergic rhinitis
FDA approves expanded use of Ryaltris nasal spray for children aged 6 to less than 12 years.
What this means
Ryaltris is a nasal spray combining an antihistamine and a steroid to treat seasonal allergy symptoms like sneezing and congestion. The FDA has now approved its use for children as young as six years old. This gives younger kids a single, convenient spray option for managing their seasonal allergies.
Drug Watch — recent news on Ryaltris
- US FDA approves Glenmark’s Ryaltris for children - ETPharma.com
- Popular allergy nasal spray urgently recalled over serious injury and poisoning risk - MSN
- Doctor explains new allergy nasal spray approved for kids - FOX 32 Chicago
- Olbas extends range with dual-purpose Anti Allergy Nasal Spray ahead of hay fever season - Grocery Trader
- Olbas adds new Anti Allergy Nasal Spray as hay fever season looms - conveniencestore.co.uk